rs59228224
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP4BA1BP7
This summary comes from the ClinGen Evidence Repository: The NM_001100.4:c.809-35del variant in ACTA1 is an intronic variant which is located in the 3’ non-canonical splice site of intron 5. The population filtering allele frequency in gnomAD v4.1.0 is 0.2723 (20520/74490 alleles with 2805 homozygotes) in the African/African American population, which is higher than the ClinGen Congenital Myopathies VCEP threshold for BA1, and therefore meets this criterion (BA1). The results from the in silico predictor, SpliceAI, suggest that the variant does not impact ACTA1 function and it occurs at a nucleotide that is not conserved as shown by the UCSC Browser (BP4, BP7). In summary, this variant meets the criteria to be classified as benign for alpha-actinopathy based on the ACMG/AMP criteria applied, as specified by the ClinGen Congenital Myopathies VCEP: BA1, BP7 (ClinGen Congenital Myopathies VCEP specifications version 1; 08/07/2024). LINK:https://erepo.genome.network/evrepo/ui/classification/CA147050/MONDO:0100084/169
Frequency
Consequence
NM_001100.4 intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -10 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ACTA1 | ENST00000366684.7 | c.809-35delG | intron_variant | Intron 5 of 6 | 1 | NM_001100.4 | ENSP00000355645.3 | |||
ACTA1 | ENST00000366683.4 | c.809-35delG | intron_variant | Intron 5 of 6 | 5 | ENSP00000355644.4 | ||||
ACTA1 | ENST00000684723.1 | c.674-35delG | intron_variant | Intron 4 of 5 | ENSP00000508084.1 | |||||
ENSG00000290037 | ENST00000702606.1 | n.*98delC | downstream_gene_variant |
Frequencies
GnomAD3 genomes AF: 0.206 AC: 31071AN: 151054Hom.: 3427 Cov.: 27
GnomAD3 exomes AF: 0.146 AC: 31739AN: 217818Hom.: 3779 AF XY: 0.143 AC XY: 17036AN XY: 119100
GnomAD4 exome AF: 0.178 AC: 260120AN: 1457272Hom.: 23911 Cov.: 29 AF XY: 0.178 AC XY: 128917AN XY: 724270
GnomAD4 genome AF: 0.206 AC: 31110AN: 151166Hom.: 3438 Cov.: 27 AF XY: 0.204 AC XY: 15036AN XY: 73840
ClinVar
Submissions by phenotype
not specified Benign:2
- -
- -
Alpha-actinopathy Benign:1
The NM_001100.4:c.809-35del variant in ACTA1 is an intronic variant which is located in the 3’ non-canonical splice site of intron 5. The population filtering allele frequency in gnomAD v4.1.0 is 0.2723 (20520/74490 alleles with 2805 homozygotes) in the African/African American population, which is higher than the ClinGen Congenital Myopathies VCEP threshold for BA1, and therefore meets this criterion (BA1). The results from the in silico predictor, SpliceAI, suggest that the variant does not impact ACTA1 function and it occurs at a nucleotide that is not conserved as shown by the UCSC Browser (BP4, BP7). In summary, this variant meets the criteria to be classified as benign for alpha-actinopathy based on the ACMG/AMP criteria applied, as specified by the ClinGen Congenital Myopathies VCEP: BA1, BP7 (ClinGen Congenital Myopathies VCEP specifications version 1; 08/07/2024). -
not provided Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at